Search results for "Maculopapular rash"

showing 4 items of 4 documents

Abstract PS11-11: Targeted safety events from a phase I/Ib study evaluating GDC-0077 alone and in combination with endocrine therapy (ET) ± palbocicl…

2021

Abstract Background Activating mutations in PIK3CA, encoding the p110α subunit of phosphatidylinositol 3-kinase (PI3K) occur in ~40% of HR+/HER2- BCs. GDC-0077, a PI3Kα-selective inhibitor and mutant PI3Kα degrader, is being developed as an anticancer agent. A phase I/Ib study of GDC-0077 alone and combined with other therapies is ongoing in pts with locally advanced or metastatic PIK3CAmut, HR+/HER2- mBC (NCT03006172). Targeted safety events are presented here. Methods Safety was assessed via NCI-CTCAE v4 for GDC-0077 administered alone (Arm A), with letrozole and palbo (Arm B), with letrozole (Arm C), with fulvestrant (Arm D), or with fulvestrant and palbo (Arm E, plus metformin in Arm F …

Cancer Researchmedicine.medical_specialtyFulvestrantbusiness.industryCumulative doseLetrozolePalbociclibNeutropeniamedicine.diseaseRashMetastatic breast cancerGastroenterologyOncologyInternal medicineMaculopapular rashmedicinemedicine.symptombusinessmedicine.drugCancer Research
researchProduct

Fatal hypersensitivity reaction to an oral spray of flurbiprofen: a case report

2013

Summary What is known and objective Safety of the anti-inflammatory drug flurbiprofen is comparable with that of other non-steroidal anti-inflammatory drugs of the propionic acid class, which are commonly associated with gastrointestinal and renal side effects. Here we report a case of a fatal hypersensitivity reaction to an oral spray of flurbiprofen taken for sore throat. Case summary A 29-year-old man came to the emergency care unit reporting sore throat with an intense burning sensation associated with fever. Pharyngotonsillitis was diagnosed, and local treatment with oral flurbiprofen spray was prescribed. Immediately after using the spray, the patient experienced a severe reaction cha…

AdultMaleoral sprayAllergyAdministration TopicalFlurbiprofenAdministration OralFatal hypersensitivity reaction; oral spray; flurbiprofenadverse Effect; adverse reaction; anti inflammatory; fatal reaction; flurbiprofen; hypersensitivity; NSAID; pharmacovigilance; sprayDrug HypersensitivitySettore MED/43 - Medicina LegalemedicineMaculopapular rashSore throatHumansPharmacology (medical)Fatal hypersensitivity reactionCause of deathPharmacologyAsphyxiabusiness.industryAnti-Inflammatory Agents Non-SteroidalPharyngitismusculoskeletal systemmedicine.diseaseflurbiprofenHypersensitivity reactionAnesthesiaItchinglipids (amino acids peptides and proteins)Oral Spraysmedicine.symptombusinessmedicine.drugJournal of Clinical Pharmacy and Therapeutics
researchProduct

Klebsiella oxitoca folliculitis mimicking tinea barbae in a diabetic man

2005

A 55-year-old male dairy farmer was admitted to our hospital with a skin infection on the neck and face. He was apparently in good general health, and his medical history was unremarkable. He reported that, 50 days before admission, a pruritic red maculopapular rash had developed on the anterior region of his neck. This rash failed to improve after a 10-day course of trimethoprim-sufamethoxazole and fluconazole; rather it progressively worsened. On admission, examination revealed confluent follicular papulae-pustules with purulent-hematic exudation and crusting, on an erythematous-edematous area extending over the anterior region of the neck, chin and mandible (Fig. 1); hairs within the aff…

MalePathologymedicine.medical_specialtyScarsCeftazidimeFolliculitisDermatologyCeftazidimeDiabetes ComplicationsmedicineMaculopapular rashHumansAmikacinTinea barbaeMycosismedicine.diagnostic_testbusiness.industryAmikacin Anti-Bacterial Agents CeftazidimeDiabetes ComplicationsKlebsiella oxytocaMiddle Agedmedicine.diseaseRashDermatologyAnti-Bacterial AgentsKlebsiella InfectionsTreatment OutcomeFaceErythrocyte sedimentation ratemedicine.symptombusinessmedicine.drugInternational Journal of Dermatology
researchProduct

Maculopapular rash and fever: a diagnostic challenge to the paediatrician in the COVID-19 pandemic

2021

Introduction: Several clinical conditions can manifest with fever and a maculopapular rash in paediatric age. Although some presentations are benign, others may be medical emergencies, which demand a prompt diagnosis and treatment. Some of the more common causes of fever and maculopapular rash include infectious diseases (Sars-CoV-2, Parvovirus B19; Coxsackie; Epstein-Barr virus infection, Mycoplasma Pneumoniae, etc), hypersensitivity reactions, Autoinflammatory syndromes, vasculitis, Kawasaki disease (KD), autoimmune diseases. Objectives: In the COVID-19 pandemic era these symptoms need a well-organized hospital strategy to rapidly exclude Sars-CoV-2 infection and to distinguish severe and…

Settore MED/38 - Pediatria Generale E SpecialisticaCOVID-19Maculopapular rash
researchProduct